The Leadership Team at MyOme is responsible for setting the strategic direction of the company, fostering innovation in clinical-grade whole genome sequencing, and ensuring alignment across departments. Comprising co-founders and key executives, they drive research initiatives, oversee technology development, and engage with stakeholders to enhance disease risk assessment and improve patient outcomes.